Skip to content

Clinical trials

Completed Lymphoma, B-Cell, Marginal Zone trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Completed Country / region: Poland Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20141
20171
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company1
Gilead Sciences1
Incyte Corporation1
Janssen Research & Development, LLC1
Loxo Oncology, Inc.1
Polish Lymphoma Research Group1
Prelude Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone7
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Follicular4
Lymphoma3
Lymphoma, Mantle-Cell3
Lymphoma, Non-Hodgkin3
Waldenstrom Macroglobulinemia3
Lymphoma, B-Cell2
Dendritic Cell Sarcoma, Interdigitating1
Hematologic Diseases1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.